Depression 5 - Clinical (3)

[P431] Lumateperone in the Treatment of Patients With Major Depressive Disorder and Bipolar Disorder With Anxious Distress and Mixed Features

*Zubin Bhagwagar¹, Susan G. Kozauer¹, Willie R. Earley¹, Jason Huo¹, Gary S. Sachs^2,3, Suresh Durgam¹ (1. Intra-Cellular Therapies, Inc., New York, NY, USA, 2. Massachusetts General Hospital, Boston, Massachusetts, USA, 3. Signant Health, Plymouth Meeting, Pennsylvania, USA)

Keywords:lumateperone, major depressive disorder, bipolar disorder, mixed features, anxious distress